Hypothalamo-preoptic Histaminergic Projections in Sleep-Wake Control in the Cat

Authors

  • J. S. Lin,

    Corresponding author
    1. Département de Médecine Expérimental, INSERM U52, CNRS UA 1195, Université Claude Bernard, 8 avenue Rockefeller, 69373 Lyon, France
    Search for more papers by this author
  • K. Sakai,

    1. Département de Médecine Expérimental, INSERM U52, CNRS UA 1195, Université Claude Bernard, 8 avenue Rockefeller, 69373 Lyon, France
    Search for more papers by this author
  • M. Jouvet

    1. Département de Médecine Expérimental, INSERM U52, CNRS UA 1195, Université Claude Bernard, 8 avenue Rockefeller, 69373 Lyon, France
    Search for more papers by this author

J. S. Lin, as above

Abstract

Cats were chronically implanted with electrodes for polygraphic recordings and cannulae for intracerebral microinjections in order to study the functional role of histaminergic innervation of the preoptic-anterior hypothalamus in sleep-wake control. α-Fluoromethylhistidine (αFMH, 50 μg in 1 μl), a specific inhibitor of the histamine-synthesizing enzyme, when injected bilaterally into the preoptic area, where numerous histaminergic fibres and terminal-like structures are present, caused a significant increase in deep slow wave sleep (S2) and paradoxical sleep (PS) and a decrease in wakefulness. In contrast, microinjections of histamine (5 or 30 μg in 1 μl) in the same area dose-relatedly increased wakefulness and decreased both slow wave sleep and paradoxical sleep. The effects of histamine were reduced by pretreatment with mepyramine (1 mg/kg i. p.), a well known histamine H1 receptor antagonist, and were mimicked by a local injection of impromidine (1 μg in 1 μl), a potent histamine H2 receptor agonist. Microinjections of mepyramine alone (120 μg in 1 μl) caused an increase in slow wave sleep. These results suggest that preoptic histaminergic innervation is involved in sleep-wake control and that the action might be mediated via both H1 and H2 receptors.

Ancillary